2 completed. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Completed 2 |
Follow Ian F. Pollack, M.D.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| HLA-A2-Restricted Glioma Antigen-Peptides Vaccinations With Poly-ICLC for Recurrent WHO Grade II Gliomas Peptide vaccine + Poly-ICLC - Astrocytoma, Oligoastrocytoma | Early Phase 1 | Completed | Ian F. Pollack, M.D. | 10 | 2009-04-01 | 2015-12-08 |
| Effects of Vaccinations With HLA-A2-Restricted Glioma Antigen-Peptides in Combination With Poly-ICLC for Adults With High-Risk WHO Grade II Astrocytomas and Oligo-Astrocytomas GAA/TT-peptide vaccine and poly-ICLC - Astrocytoma, Oligo-Astrocytoma | Early Phase 1 | Completed | Ian F. Pollack, M.D. | 13 | 2009-01-01 | 2019-08-30 |
Astrocytoma (2) · Glioma (1) · Neoplasms (1) · Oligodendroglioma (1)
poly ICLC (2) · Protein Subunit Vaccines (1)
United States (2)
R21CA133859 (2)